Literature DB >> 9881257

Gliomatosis cerebri: findings with computed tomography and magnetic resonance imaging.

P Ponce1, M V Alvarez-Santullano, E Otermin, M A Santana, M V García Ludeña.   

Abstract

Gliomatosis cerebri (GC), is a rare neoplastic disease (less than 150 cases reported in the literature) with a diffuse, widespread proliferation of neoplastic glial cells in the brain, generally affecting both hemispheres and involving the gray and white matter [1-3]. Less commonly, the cerebellum, the brain stem and the medulla can be affected. Histologic evaluation reveals neoplastic astrocytes with varying levels of differentiation. Perineuronal and perivascular spread of tumor infiltration is observed. Demyelination can be found in the affected areas. A well-preserved underlying neuroanatomic architecture is considered characteristic [2]. Clinical signs vary and are non-specific, including changes in the mental state and headaches, followed by focal motor deficits and convulsive episodes [4]. The prognosis is poor, ranging from weeks to some years after the manifestation of the symptoms. Steroids may be useful in the short term, but chemotherapy is of little value and radiotherapy of questionable benefit. The literature was reviewed and the radiological pattern of three new cases of GC is reported. In two cases the diagnosis was achieved ante-mortem.

Entities:  

Mesh:

Year:  1998        PMID: 9881257     DOI: 10.1016/s0720-048x(97)00172-1

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  6 in total

1.  Histological and genetic diagnosis of gliomatosis cerebri: case report.

Authors:  S M Yamada; Y Hayashi; H Takahashi; A Teramoto; K Matsumoto; S Yamada
Journal:  J Neurooncol       Date:  2001-05       Impact factor: 4.130

2.  MRI features of gliomatosis cerebri in a dog.

Authors:  Paula Martin-Vaquero; Ronaldo C da Costa; Kendra E Wolk; Christopher Premanandan; Michael J Oglesbee
Journal:  Vet Radiol Ultrasound       Date:  2012 Mar-Apr       Impact factor: 1.363

3.  Prognostic factors for patients with gliomatosis cerebri: retrospective analysis of 17 consecutive cases.

Authors:  Tomoo Inoue; Toshihiro Kumabe; Masayuki Kanamori; Yukihiko Sonoda; Mika Watanabe; Teiji Tominaga
Journal:  Neurosurg Rev       Date:  2011-02-08       Impact factor: 3.042

4.  Histological and MR correlations in Gliomatosis cerebri.

Authors:  Paule Peretti-Viton; Hervé Brunel; Olivier Chinot; Clément Daniel; Maryline Barrié; Corinne Bouvier; Dominique Figarella-Branger; Stéphane Fuentes; Henry Dufour; François Grisoli
Journal:  J Neurooncol       Date:  2002-09       Impact factor: 4.130

5.  Procarbazine, CCNU, and Vincristine Chemotherapy in Gliomatosis Cerebri.

Authors:  Hyun Gon Lee; Keun Soo Lee; Won Hee Lee; Sung Tae Kim
Journal:  Brain Tumor Res Treat       Date:  2014-10-31

6.  Pediatric gliomatosis cerebri mimicking tubercular encephalitis.

Authors:  Namit Singhal; Vinay Agarwal
Journal:  J Pediatr Neurosci       Date:  2015 Oct-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.